Speciality Generic Injectables
Biological E. Limited has invested in building an API facility and a Formulations facility at Shamirpet (outskirts of Hyderabad, India). Both these greenfield facilities are operational.
The API facility has about 72,000 square feet of built-up space. Presently, this facility is equipped for manufacturing Enoxaparin and Noscapine. The API facility has been inspected by the WHO. Currently, about 450 people work in the API facility.
The Formulations facility has about 102,000 square feet of built-up space. This facility is currently equipped for manufacturing injectable products in vials (liquid and lyophilized) and pre-filled syringes. The US FDA, WHO and Infarmed (Portugal), has inspected the Formulations facility. Currently, about 350 people work in the formulations facility.